Discovery of thiosemicarbazone derivatives as effective New Delhi metallo-β-lactamase-1 (NDM-1) inhibitors against NDM-1 producing clinical isolates
New Delhi metallo-β-lactamase-1 (NDM-1) is capable of hydrolyzing nearly all β-lactam antibiotics, posing an emerging threat to public health. There are currently less effective treatment options for treating NDM-1 positive "superbug", and no promising NDM-1 inhibitors were used in clinica...
Saved in:
Main Authors: | Bing Zhao (Author), Xinhui Zhang (Author), Tingting Yu (Author), Ying Liu (Author), Xiaoling Zhang (Author), Yongfang Yao (Author), Xuejian Feng (Author), Hongmin Liu (Author), Dequan Yu (Author), Liying Ma (Author), Shangshang Qin (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prediction of Phytochemicals for Their Potential to Inhibit New Delhi Metallo β-Lactamase (NDM-1)
by: Zainab Bibi, et al.
Published: (2023) -
Metallo-Beta-Lactamases: NDM
by: Kamil Leis, et al.
Published: (2019) -
Metallo-Beta-Lactamases: NDM
by: Kamil Leis, et al.
Published: (2019) -
Pharmacophore-Based Study: An In Silico Perspective for the Identification of Potential New Delhi Metallo-β-lactamase-1 (NDM-1) Inhibitors
by: Heba Ahmed Alkhatabi, et al.
Published: (2024) -
Inpatient point-prevalence screening of New Delhi Metallo-β-lactamase (NDM)-producing Enterobacaterales and Candida auris
by: Christian Greco, et al.
Published: (2022)